We are live on ! Find out more
MS

Murray Stahl Horizon Kinetics Asset Management

AUM $8.82B
1-Year Est. Return 23.05%
 

Murray Stahl is chairman of Horizon Kinetics, an investment firm known for independent research and unconventional long-term themes. The firm has been closely associated with ideas such as hard assets, owner-operator businesses, and differentiated equity research outside the consensus. Stahl’s commentaries are followed by investors interested in structural market inefficiencies and long-duration themes.

This Fund
S&P 500
This Quarter Est. Return
+18.34%
1 Year Est. Return
+23.05%
3 Year Est. Return
+192.13%
5 Year Est. Return
+221.88%
10 Year Est. Return
AUM
$5.05B
AUM Growth
+$406M
Cap. Flow
-$225M
Cap. Flow %
-4.46%
Top 10 Hldgs %
72.02%
Holding
345
New
11
Increased
64
Reduced
153
Closed
14

Sector Composition

Rank Sector Weight
1 Energy 56.85%
2 Materials 8.62%
3 Financials 8.12%
4 Consumer Discretionary 4.41%
5 Technology 3.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PML
301
PIMCO Municipal Income Fund II
PML
$484M
$116K ﹤0.01%
15,050
BLUE
302
DELISTED
bluebird bio
BLUE
$116K ﹤0.01%
1,900
EVV
303
Eaton Vance Limited Duration Income Fund
EVV
$1.05B
$113K ﹤0.01%
12,456
SSP icon
304
E.W. Scripps
SSP
$303M
$110K ﹤0.01%
20,000
GALT icon
305
Galectin Therapeutics
GALT
$371M
$108K ﹤0.01%
56,000
KYN icon
306
Kayne Anderson Energy Infrastructure Fund
KYN
$2.47B
$106K ﹤0.01%
12,564
+7
+0.1% +$60
JPS
307
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$102K ﹤0.01%
16,601
LTRN icon
308
Lantern Pharma
LTRN
$29.9M
$102K ﹤0.01%
30,000
PACB icon
309
Pacific Biosciences
PACB
$420M
$100K ﹤0.01%
12,000
NMZ icon
310
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.16B
$96.2K ﹤0.01%
10,369
NUV icon
311
Nuveen Municipal Value Fund
NUV
$1.88B
$95.4K ﹤0.01%
11,550
VTN icon
312
Invesco Trust for Investment Grade New York Municipals
VTN
$157M
$94.9K ﹤0.01%
10,414
TSVT
313
DELISTED
2seventy bio
TSVT
$70.6K ﹤0.01%
18,000
EFXT
314
Enerflex
EFXT
$2.48B
$66.8K ﹤0.01%
+11,655
New +$78.3K
ALLO icon
315
Allogene Therapeutics
ALLO
$722M
$63.4K ﹤0.01%
20,000
VVR icon
316
Invesco Senior Income Trust
VVR
$454M
$39.2K ﹤0.01%
10,000
RAIN
317
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$21.5K ﹤0.01%
25,000
DCOY
318
Decoy Therapeutics
DCOY
$2.1M
$21.3K ﹤0.01%
23
KEEL
319
Keel Infrastructure Corp
KEEL
$2.05B
$19.6K ﹤0.01%
18,300
NCNA
320
NuCana
NCNA
$6.33M
$11.9K ﹤0.01%
4
GBX icon
321
The Greenbrier Companies
GBX
$1.42B
$10K ﹤0.01%
10,000
+500
+5% +$21.5K
TCRT icon
322
Alaunos Therapeutics
TCRT
$4.47M
$4.48K ﹤0.01%
227
MANA
323
DELISTED
MANATRON INC
MANA
$3.44K ﹤0.01%
691
POL.WS
324
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
$113 ﹤0.01%
37,752
ALCO icon
325
Alico
ALCO
$299M
-7,900
Closed -$201K

Similar funds

Murray Stahl's Q3 2023 Portfolio in Review

As of Q3 2023, Murray Stahl held 345 positions worth $5.05B, up 8.7% from $4.64B the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Murray Stahl withdrew a net $225M in Q3 2023, closing 14 positions and reducing 153 holdings. Its most notable exit was ABB Ltd, an estimated $1.17M position sold in full.

By sector, the portfolio is most concentrated in Energy at 57% of assets, up from 48% a quarter earlier, followed by Materials and Financials.

Against the trend, Murray Stahl opened a new position in Burford Capital worth $5.27M.

  • Murray Stahl's largest Q3 2023 buy was Burford Capital: 376,073 shares worth $5.27M.
  • Murray Stahl added most to Horizon Kinetics SPAC Active ETF in Q3 2023, an estimated $1.93M increase.
  • Murray Stahl's biggest Q3 2023 reduction was ProShares Short VIX Short-Term Futures ETF, cutting an estimated $60.1M.
  • Murray Stahl fully exited ABB Ltd in Q3 2023, selling an estimated $1.17M.
  • Murray Stahl's ten largest holdings make up 72% of its $5.05B portfolio in Q3 2023.
  • Murray Stahl opened 11 new positions and closed 14 in Q3 2023.
  • Murray Stahl's portfolio value rose 8.7% quarter-over-quarter to $5.05B.

Based on Horizon Kinetics Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.